About Emerald Clinical Trials India Private Limited
Data last updated:
Emerald Clinical Trials India Private Limited is a foreign private limited company based in Bangalore, Karnataka, India, a subsidiary of George Clinical Pty Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 04 October 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2012FTC080639. Its GSTIN is 29AAECG9603L1Z6 (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Mamatha Thankam Jacob and Ghosh Dwaipayan.
Its last annual general meeting (AGM) was held on 25 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹46.42 Cr, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹4.22 Cr (net margin 9.1%) and EBITDA of ₹6.18 Cr (EBITDA margin 13.3%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 32% over five years.
The company has about 103 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: George Clinical. Court records list 7 cases involving the company, including 7 filed by the company; 6 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website georgeclinical.com.
Company details
CIN history
Emerald Clinical Trials India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U73100KA2012FTC080639, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100KA2012FTC080639 | Current |
| U73100AP2012FTC083414 | Previous |
| U73100TG2012FTC083414 | Previous |
Contact details
Emerald Clinical Trials India Private Limited's registered office is in Bangalore, Karnataka. Its website is georgeclinical.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressMunicipal No – 5 12th Floor Prestige Khoday Towers, Raj Bhavan Road, Bangalore, Karnataka, India – 560001
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Emerald Clinical Trials India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Emerald Clinical Trials India operates one associated brand: George Clinical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Full-service CRO services for Phase I-IV clinical trials are provided. | georgeclinical.com |
Business activity
The main business activity of Emerald Clinical Trials India is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Emerald Clinical Trials India Private Limited, buy the company report.
Financials of Emerald Clinical Trials India Private Limited
FY 2024 filings availableEmerald Clinical Trials India Private Limited reported revenue of ₹46.42 Cr (down 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 28% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 32%. EBITDA fell 72% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.18 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.22 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.3% | ||||
| Net Profit Margin | 9.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Emerald Clinical Trials India Private Limited, buy the company report.
Board of directors of Emerald Clinical Trials India Private Limited
Emerald Clinical Trials India has 3 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mamatha Thankam Jacob | Director | 26 Sep 2024 | 2 Years 1 Months | Current |
| Ghosh Dwaipayan | Director | 12 Jun 2025 | 1 Years 4 Months | Current |
| Anthony Stephen Proctor | Director | 08 Oct 2025 | 1 Years 0 Months | Current |
Auditor
Emerald Clinical Trials India Private Limited is audited by MSKA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MSKA & ASSOCIATES | FY 2023 | 105047W |
Shareholding
The shareholding of Emerald Clinical Trials India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Emerald Clinical Trials India Private Limited, buy the company report.
Legal cases
Emerald Clinical Trials India Private Limited has 7 court cases on record: 7 filed by Emerald Clinical Trials India. 6 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 0 | 6 |
Cases on record (4 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed by the company against The Assistant Commissioner of Central Tax | Pending |
| High Court of Karnataka | Writ petition | Filed by the company against The Assistant Commissioner of Central Taxes | Pending |
| High Court of Karnataka | Writ petition | Filed by the company against Union of India | Pending |
| High Court of Karnataka | Writ petition | Filed by the company against Union of India | Disposed |
To see the full case history of Emerald Clinical Trials India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Emerald Clinical Trials India Private Limited has 1 MSME Form 1 return on record for the period ending Sep 2022, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Mount Print Zone |
To see the full MSME payment records of Emerald Clinical Trials India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Emerald Clinical Trials India Private Limited has a workforce of 103 employees on its EPFO records as of Apr 08, 2024, across 2 active EPFO establishments.
GST
Emerald Clinical Trials India has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECG9603L1Z6 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Emerald Clinical Trials India Private Limited, buy the company report.
Recent activity
Emerald Clinical Trials India Private Limited has 17 board changes on record since 2013: 5 appointments and 12 cessations. The latest: Anthony Stephen Proctor was appointed as Director on 08 Oct 2025.
8 earlier events are in the company report.
News
Frequently asked questions
Emerald Clinical Trials India is an active foreign private limited company based in Bangalore, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 04 October 2012 (14+ years old) and is registered under CIN U73100KA2012FTC080639.
Emerald Clinical Trials India has 3 current directors:
- Mamatha Thankam Jacob - Director
- Ghosh Dwaipayan - Director
- Anthony Stephen Proctor - Director
The latest financial statements of Emerald Clinical Trials India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 25 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Emerald Clinical Trials India is 29AAECG9603L1Z6, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Emerald Clinical Trials India is U73100KA2012FTC080639. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emerald Clinical Trials India has 7 court cases on record: 7 filed by the company. 6 are pending.
Emerald Clinical Trials India was incorporated on 04 October 2012, making it 14+ years old. It is registered with the Registrar of Companies, Bangalore.
Anthony Stephen Proctor was appointed as Director on 08 Oct 2025. Ghosh Dwaipayan ceased to be Additional Director on 17 Jun 2025. Ghosh Dwaipayan was appointed as Director on 12 Jun 2025. Emerald Clinical Trials India has 17 board changes on record in total.
Emerald Clinical Trials India has 1 MSME Form 1 return on record for the period ending Sep 2022, listing 1 overdue payment to 1 micro and small supplier. The latest return was filed on 29 Oct 2022.
Emerald Clinical Trials India can be reached through the website georgeclinical.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Emerald Clinical Trials India is at Municipal No – 5 12th Floor Prestige Khoday Towers, Raj Bhavan Road, Bangalore, Karnataka, India – 560001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
